The phone numbers for more information about the studies below are 1-866-444-2214 (TTY 1-866-411-1010) unless otherwise noted.
Loa Loa Study
Have you ever traveled to or lived in central or western Africa for longer than 1 month? Have you or someone you know experienced worms moving along the white part of the eye? Are you between 18 and 65 years old? NIAID is seeking volunteers to participate in a research study evaluating the effectiveness of reslizumab in reducing the side effects of the standard drug therapy used to treat Loa loa. All participants will be required to travel to NIH for an overnight stay. All study-related tests or treatment are provided at no cost. Refer to study 10-I-0101. Se habla español.
Do you suffer with seizures? Consider participating in a study evaluating and treating people with epilepsy. Individuals will undergo standard diagnostic procedures used to determine the type of seizures, causes and whether standard drug treatment can help them. All study-related tests are provided at no cost. Refer to study 01-N-0139.
Volunteers are needed for a study examining immune function in healthy volunteers given short-term treatment of sitagliptin. Investigators wish to determine if and how sitagliptin alters immune function. If you are 18 years or older and healthy, consider participating in this study. All study-related tests are provided at no cost. Compensation is provided. Refer to study 09-DK-0055.
Seeking Patients with Wet Age-Related Macular Degeneration
The Food and Drug Administration has approved the use of Lucentis for treatment of wet age-related macular degeneration. The National Eye Institute is looking for volunteers 50 years and older with wet age-related macular degeneration to participate in a study exploring the different responses to the drug Lucentis. Participants will be required to travel to NIH on an outpatient basis for the initial evaluation and subsequent monthly examinations. Refer to study 08-EI-0103.Se habla español.
Hepatitis B Study
Did you receive the hepatitis B vaccine or did you recover from acute hepatitis B more than 10 years ago? Would you like to know if you still have protective antibody levels? Consider participating in the Hepatitis B Vaccine Immunity Study. This study consists of one outpatient clinic visit for a blood draw and a short research questionnaire. Participants must have been 18 years of age or older and younger than age 60 when the hepatitis B vaccine was administered. The vaccine must have been given prior to the year 2000. Individuals who have a history of chronic HBV infection or those who did not receive all 3 doses of HBV vaccine are not eligible for participation. For more information, call (301) 435-6121. Refer to study 10-DK-0187. Compensation is provided.
Liver Diseases Study
Individuals with liver disease are needed for NIH study. NIDDK is conducting studies on liver diseases including hepatitis B, C, and D, primary biliary cirrhosis, nonalcoholic steatohepatitis (NASH), fatty liver disease, autoimmune hepatitis, portal hypertension not due to cirrhosis, acute hepatitis from any cause and rare or unexplained liver disorders. Studies are conducted at the Clinical Center. There is no cost for study-related medications, tests or treatments. Must be 18 years of age or older. Refer to study 91-DK-0214.